Resmed Valuation
| RMD Stock | 38.59 0.48 1.26% |
At this time, the company appears to be overvalued. Resmed Inc DRC holds a recent Real Value of USD31.61 per share. The prevailing price of the company is USD38.59. Our model determines the value of Resmed Inc DRC from analyzing the company fundamentals such as Return On Equity of 0.24, shares outstanding of 1.47 B, and Operating Margin of 0.32 % as well as examining its technical indicators and probability of bankruptcy.
Price Book 7.0599 | Enterprise Value 57.2 B | Enterprise Value Ebitda 22.7801 | Price Sales 11.7254 | Forward PE 27.3224 |
Overvalued
Today
Please note that Resmed's price fluctuation is very steady at this time. Calculation of the real value of Resmed Inc DRC is based on 3 months time horizon. Increasing Resmed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Resmed's intrinsic value may or may not be the same as its current market price of 38.59, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 38.59 | Real 31.61 | Hype 38.61 | Naive 39.99 |
The intrinsic value of Resmed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Resmed's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Resmed Inc DRC helps investors to forecast how Resmed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Resmed more accurately as focusing exclusively on Resmed's fundamentals will not take into account other important factors: Resmed Cash |
|
Resmed Total Value Analysis
Resmed Inc DRC is at this time forecasted to have takeover price of 57.19 B with market capitalization of 56.37 B, debt of 873.93 M, and cash on hands of 273.71 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Resmed fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
57.19 B | 56.37 B | 873.93 M | 273.71 M |
Resmed Investor Information
The company has Price/Earnings To Growth (PEG) ratio of 1.9. Resmed Inc DRC last dividend was issued on the 6th of November 2024. The entity had 2:1 split on the 12th of August 2010. Based on the measurements of operating efficiency obtained from Resmed's historical financial statements, Resmed Inc DRC is performing exceptionally good at this time. It has a great probability to report excellent financial results in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 1.5 B | 1.4 B |
|
| |||||
| Operating Income | 1.4 B | 1.3 B |
|
|
Resmed Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Resmed has an asset utilization ratio of 68.18 percent. This implies that the Company is making USD0.68 for each dollar of assets. An increasing asset utilization means that Resmed Inc DRC is more efficient with each dollar of assets it utilizes for everyday operations.Resmed Ownership Allocation
Resmed owns a total of 1.47 Billion outstanding shares. Roughly 89.49 pct. of Resmed outstanding shares are held by general public with 10.51 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Resmed Profitability Analysis
The company reported the revenue of 4.69 B. Net Income was 1.02 B with profit before overhead, payroll, taxes, and interest of 2.39 B.About Resmed Valuation
The stock valuation mechanism determines Resmed's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Resmed Inc DRC based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Resmed. We calculate exposure to Resmed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Resmed's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.7 B | 2.8 B |
Resmed Quarterly Retained Earnings |
|
Additional Tools for Resmed Stock Analysis
When running Resmed's price analysis, check to measure Resmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Resmed is operating at the current time. Most of Resmed's value examination focuses on studying past and present price action to predict the probability of Resmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Resmed's price. Additionally, you may evaluate how the addition of Resmed to your portfolios can decrease your overall portfolio volatility.